NONMEM Users Network Archive

Hosted by Cognigen

Fellowship Program for Young Researchers

From: Husain Attarwala <Husain.Attarwala>
Date: Wed, 6 Oct 2021 13:29:13 +0000

Dear All,

In order to further research in the area of mRNA therapeutics, as well as i=
n disease areas currently under investigation by Moderna, we are pleased to=
 offer the opportunity to support research fellowships. These fellowships a=
re intended to support research in a wide array of disciplines including ph=
armacometrics. The application process is intended to be as simple as possi=
ble, institutions apply with a named supervisor and fellow. The fellowship =
will be awarded for between 1 and 3 years, and will support salary costs an=
d research expenses. The program will launch in 2022, and the deadline for =
applications is December 31st 2021. Successful applications will be informe=
d of the decision by March 31st 2022.

To apply, please download and fill the application form below. Return your =
completed application to global.fellowships
lowships

Application form<https://www.modernatx.com/sites/default/files/u2406/Modern=
a-GlobalFellowshipApplicationv4.pdf>

https://www.modernatx.com/research-fellowship

Regards,

Husain Attarwala, PhD
Director & Head, Clinical Pharmacology and Pharmacometrics | Moderna
mobile (617) 840-0805 | office (617) 803-3425 | modernatx.com<http://modern=
atx.com/>
 [signature_2127785708] <http://www.modernatx.com/>
[signature_1146048737]<http://facebook.com/modernatx/> [signature_11817=
6511] <https://twitter.com/moderna_tx> [signature_1781966198] <http://=
youtube.com/user/ModernaTx> [signature_1489564253] <https://linkedin.c=
om/company/moderna->



P Please consider the environment before printing this email


Confidentiality notice and disclaimer: The information in this message and =
any attachments is intended for the exclusive use of the addressee(s), is c=
onfidential and may be privileged or otherwise protected from disclosure. A=
ny review, retransmission, dissemination or other use of, or taking of any =
action in reliance upon, of any such information by persons or entities oth=
er than the intended addressee(s) is prohibited. If you have received this =
message in error and are not the intended addressee, please notify the send=
er immediately and delete this message and any attachments from your system=
 without reading or disclosing them. If you are not the intended addressee,=
 be advised that any use of the information in this message and any attachm=
ent is prohibited and may be unlawful, and you must not copy this message o=
r attachment or disclose the contents to any other person.




image011.jpg
(image/jpeg attachment: image011.jpg)

image012.jpg
(image/jpeg attachment: image012.jpg)

image013.jpg
(image/jpeg attachment: image013.jpg)

image014.jpg
(image/jpeg attachment: image014.jpg)

image015.jpg
(image/jpeg attachment: image015.jpg)

Received on Wed Oct 06 2021 - 09:29:13 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com.

Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.